Yu Sun Selected Research

Long Noncoding RNA

2/2024	Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease.
1/2023	Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling.
11/2022	Overexpression of long non-coding RNA LINC00158 inhibits neuronal apoptosis by promoting autophagy in spinal cord injury.
10/2022	DLRAPom: a hybrid pipeline of Optimized XGBoost-guided integrative multiomics analysis for identifying targetable disease-related lncRNA-miRNA-mRNA regulatory axes.
12/2021	Knockdown of long non-coding RNA NEAT1 relieves the inflammatory response of spinal cord injury through targeting miR-211-5p/MAPK1 axis.
12/2020	Long noncoding RNA PTCSC1 drives esophageal squamous cell carcinoma progression through activating Akt signaling.
4/2020	LINC00473 inhibits vascular smooth muscle cell viability to promote aneurysm formation via miR-212-5p/BASP1 axis.
1/2020	Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
1/2020	Transcribed Ultraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulating the Transcription of CPT1b (Carnitine Palmitoyl transferase 1b).
11/2019	LncRNA-DANCR promotes growth and metastasis of colorectal cancer via activating epithelial-mesenchymal transition process.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Sun Research Topics

Disease

334	Neoplasms (Cancer) 05/2024 - 06/2005
79	Inflammation (Inflammations) 02/2024 - 10/2007
48	Infections 04/2024 - 07/2007
47	Neoplasm Metastasis (Metastasis) 04/2024 - 06/2005
42	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2007
40	Fibrosis (Cirrhosis) 01/2023 - 03/2011
27	Wounds and Injuries (Trauma) 01/2024 - 02/2011
27	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 07/2003
26	Hypertension (High Blood Pressure) 12/2024 - 04/2006
26	Ischemic Stroke 01/2024 - 04/2012
26	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2009
25	Stomach Neoplasms (Stomach Cancer) 04/2024 - 02/2006
25	Hypoxia (Hypoxemia) 02/2024 - 02/2002
24	Lung Neoplasms (Lung Cancer) 11/2023 - 12/2007
22	Carcinoma (Carcinomatosis) 10/2023 - 08/2004
21	Carcinogenesis 05/2024 - 01/2007
21	Insulin Resistance 01/2024 - 03/2012
20	Stroke (Strokes) 11/2024 - 08/2009
20	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 04/2006
19	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2009
19	Cognitive Dysfunction 10/2023 - 12/2016
18	Dementia (Dementias) 05/2024 - 10/2007
18	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 06/2005
17	Adenocarcinoma of Lung 01/2024 - 01/2015
17	Colonic Neoplasms (Colon Cancer) 10/2019 - 10/2008
16	COVID-19 04/2024 - 11/2020
16	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 06/2009
15	Lung Injury 08/2022 - 02/2008
14	Atherosclerosis 11/2024 - 06/2014
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 10/2007
14	Glioma (Gliomas) 10/2023 - 09/2015
14	Burns 01/2022 - 02/2010
13	Adenocarcinoma 03/2024 - 01/2009
13	Obesity 01/2024 - 09/2007
13	Reperfusion Injury 10/2023 - 06/2010
13	Acute Lung Injury 01/2023 - 08/2006
13	Sepsis (Septicemia) 01/2022 - 11/2009
13	Cicatrix (Scar) 01/2021 - 10/2007
12	Virus Diseases (Viral Diseases) 03/2024 - 02/2011
12	Heart Failure 01/2023 - 04/2006
11	Hyperlipidemias (Hyperlipidemia) 05/2024 - 01/2015
11	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 05/2007
11	Body Weight (Weight, Body) 01/2024 - 03/2012
11	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 03/2016
11	Fatigue 10/2023 - 01/2018
11	Hyperglycemia 09/2023 - 01/2009
11	Spinal Cord Diseases 09/2023 - 08/2007
10	Necrosis 01/2024 - 01/2009
10	Hypertrophy 01/2024 - 06/2016
10	Chronic Renal Insufficiency 10/2023 - 01/2014
10	Respiratory Tract Infections (Respiratory Tract Infection) 10/2023 - 07/2007
10	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2023 - 10/2012
10	Atrial Fibrillation 01/2023 - 08/2015
10	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2013
10	Disease Progression 11/2022 - 01/2012
10	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022 - 01/2009

Drug/Important Bio-Agent (IBA)

102	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2006
77	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2011
42	CytokinesIBA 01/2023 - 06/2009
37	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 04/2008
34	RNA (Ribonucleic Acid)IBA 03/2024 - 02/2009
30	Messenger RNA (mRNA)IBA 01/2024 - 06/2005
28	LipidsIBA 02/2024 - 02/2009
25	EnzymesIBA 03/2024 - 01/2011
23	MicroRNAs (MicroRNA)IBA 12/2024 - 01/2012
23	Therapeutic UsesIBA 01/2024 - 08/2006
22	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 08/2004
20	Transcription Factors (Transcription Factor)IBA 07/2023 - 05/2007
18	Oxygen (Dioxygen)IBA 01/2024 - 05/2010
18	Interleukin-6 (Interleukin 6)IBA 11/2022 - 11/2009
17	LipopolysaccharidesIBA 02/2023 - 02/2009
16	Apolipoproteins E (ApoE)IBA 11/2024 - 11/2007
15	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2017
15	Long Noncoding RNAIBA 02/2024 - 10/2014
15	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2018
14	Small Interfering RNA (siRNA)IBA 05/2024 - 01/2007
14	CollagenIBA 01/2024 - 05/2012
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 01/2006
14	AntibodiesIBA 10/2023 - 06/2009
12	Blood Glucose (Blood Sugar)IBA 02/2024 - 09/2002
12	CholesterolIBA 01/2024 - 11/2007
12	LigandsIBA 12/2023 - 01/2009
12	Indicators and Reagents (Reagents)IBA 10/2023 - 02/2011
12	Insulin (Novolin)FDA Link 10/2023 - 01/2009
12	Immune Checkpoint InhibitorsIBA 07/2023 - 11/2018
11	Phosphotransferases (Kinase)IBA 04/2024 - 09/2011
11	Triglycerides (Triacylglycerol)IBA 02/2024 - 09/2007
11	Polysaccharides (Glycans)IBA 08/2023 - 09/2013
11	Fatty Acids (Saturated Fatty Acids)IBA 08/2023 - 10/2013
11	Hematoxylin (Haematoxylon)IBA 01/2022 - 05/2012
11	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 05/2012
10	CateninsIBA 03/2024 - 01/2013
10	AntigensIBA 10/2023 - 09/2009
10	Circular RNAIBA 04/2023 - 09/2019

Therapy/Procedure

123	Therapeutics 04/2024 - 04/2006
56	Drug Therapy (Chemotherapy) 11/2023 - 12/2008
23	Immunotherapy 03/2024 - 01/2013
21	Laminectomy 01/2022 - 09/2008
18	Transplantation 10/2023 - 02/2009
17	Radiotherapy 06/2023 - 03/2011